,,iii #aaf? ,,congress #a/ ,session ,s4 ,,res4 #afe ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,april #aa1 #bjai,ms4 ,duckwor? 7= h]self1 ,mrs4 ,blackburn1 ,mr4 ,alex&]1 ,mrs4 ,fe9/e91 ,mr4 ,re$1 ,mr4 ,s*um]1 ,mr4 ,cornyn1 ,mr4 ,br[n1 ,ms4 ,klobu*>1 ,mr4 ,:iteh\se1 ,mr4 ,b>rasso1 ,mr4 ,m]kley1 ,mr4 ,coons1 ,mr4 ,blum5?al1 ,ms4 ,baldw91 ,mr4 ,k+1 ,mr4 ,pet]s1 ,mr4 ,cassidy1 & ,mr4 ,van ,holl57 submitt$ ! foll[+ resolution2 :i* 0 consid]$ & agre$ to ,,resolution ,recogniz+ ! importance ( vacc9ations & immunizations 9 ! ,unit$ ,/ates4 ,:]eas ! contributions ( ,l\is ,pa/eur & ,edw>d ,j5n] to ! discov]y ( ! pr9ciples ( vacc9ology are among ! mo/ consequ5tial heal? f9d+s 9 human hi/ory2 ,:]eas a vacc9e made possible ! eradication ( smallpox1 sav+ millions ( lives2 ,:]eas1 because ( ! vacc9e = polio1 a highly infecti\s disease caus$ by ! poliovirus1 ! int]national community-- 7#a7 has elim9at$ polio 9 all b #c c\ntries2 & 7#b7 has sav$ an e/imat$ #ae1jjj ,am]icans f p>alysis annually2 ,:]eas vacc9es h dramatically r$uc$ ! spread ( debilitat+ & pot5tially life-?reat5+ diseases1 includ+-- 7#a7 diph!ria2 7#b7 tetanus2 7#c7 measles2 7#d7 mumps2 & 7#e7 rubella2 ,:]eas vacc9es h prev5t$ ! spread ( infecti\s & pot5tially fatal diseases1 includ+-- 7#a7 *ick5pox2 7#b7 %+les2 7#c7 influ5za2 7#d7 hepatitis ,a2 7#e7 hepatitis ,b2 7#f7 m5+ococcal disease2 7#g7 pneumococcal disease2 7#h7 rotavirus2 7#i7 p]tussis 7also kn[n z :oop+ c\gh72 & 7#aj7 m5+itis2 ,:]eas ! vacc9e-prev5table human papillomavirus 7also kn[n z ,,hpv7 is kn[n to cause c]ta9 types ( canc]2 ,:]eas ! sci5tific & m$ical communities are 9 ov]:elm+ cons5sus t vacc9es are effective & safe2 ,:]eas mis9=mation ab\t vacc9e safety & ! dissem9ation ( unf\nd$ & debunk$ !ories ab\t ! dang]s ( vacc9ations pose a great risk to public heal?2 ,:]eas sci5tifically s\nd education & outrea* campaigns ab\t ! importance ( vacc9ation & immunization are fundam5tal = a well-in=m$ public2 ,:]eas communities ) l[ vacc9ation rates compromise1 9 a p>ticul> way1 ! heal? & livelihood (-- 7#a7 infants2 7#b7 "y *ildr52 7#c7 s5iors2 7#d7 individuals ) immunodefici5cy disord]s2 & 7#e7 individuals ) weak5$ or compromis$ immune sy/ems1 includ+ individuals tak+ m$ication t affects ! immune sy/em1 su* z m$ications to treat canc]2 ,:]eas sub/antial rese>* has %[n t vacc9ation is a highly co/-effective =m ( prev5tive m$ic9e2 ,:]eas ! ,c5t]s = ,disease ,control & ,prev5tion 7ref]r$ to 9 ?is preamble z ! ,,cdc7 e/imates t1 betwe5 #aiid & #bjac1 vacc9ations sav$ ne>ly #bie1jjj1jjj1jjj 9 direct co/s & #a1chj1jjj1jjj1jjj 9 total societal co/s 9 ! ,unit$ ,/ates2 ,:]eas vacc9es 9 ! ,unit$ ,/ates-- 7#a7 und]go ext5sive safety & efficacy te/+ be=e lic5sure by ! ,food & ,drug ,adm9i/ration2 & 7#b7 are cont9ually monitor$ = adv]se ev5ts2 ,:]eas !re are #d po/-m>ket+ surveillance sy/ems 9 ! ,unit$ ,/ates track+ adv]se ev5ts aft] vacc9ation2 ,:]eas ! ,,cdc e/imates t-- 7#a7 vacc9ations w prev5t m ?an #ba1jjj1jjj hospitalizations & #gcb1jjj dea?s among *ildr5 born betwe5 #aiid & #bjac2 & 7#b7 vacc9es save ! lives ( an e/imat$ #b1ejj1jjj *ildr5 "u age #e ea* ye>2 ,:]eas #a 9 #e *ildr5 worldwide lack access to common vacc9es &1 z a result1 an e/imat$ #a1ejj1jjj p die ea* ye> f vacc9e-prev5table diseases or complications ( vacc9e-prev5table diseases1 su* z di>rhea & pneumonia2 ,:]eas /rong inve/m5ts 9 biom$ical rese>* to improve exi/+ vacc9es & develop _m m life-sav+ vacc9es are b5eficial to all p2 ,:]eas a robu/ immunization infra/ructure1 by prev5t+ & isolat+ outbreaks ( infecti\s diseases at ! s\rce1 is ess5tial to ! public heal? & well-be+ ( ! p ( ! ,unit$ ,/ates2 ,:]eas ea* ,/ate det]m9es ! vacc9ation requirem5ts = ! p ( t ,/ate2 ,:]eas ,/ate vacc9ation requirem5ts are in=m$ by recomm5dations approv$ by ! ,,cdc & develop$ by ! ,advisory ,committee on ,immunization ,practices2 ,:]eas enc\rag+ high vacc9ation rates & promot+ vacc9e confid5ce 9 ! ,unit$ ,/ates protects ! p ( ! ,unit$ ,/ates f contract+ & spread+ vacc9e-prev5table diseases2 ,:]eas ! ,_w ,heal? ,organization 7ref]r$ to 9 ?is preamble z ! ,,:o7 rec5tly id5tifi$ vacc9e hesitancy z a heal? ?reat = #bjai2 ,:]eas address+ ! _m factors t contribute to vacc9e hesitancy is crucial to increas+ vacc9ation rates & improv+ or a*iev+ h]d immunity2 ,:]eas r\t9e & up-to-date vacc9ation is ! mo/ effective me?od available to prev5t ! transmission ( pot5tially fatal infecti\s diseases2 & ,:]eas ! ,unit$ ,/ates has be5 a lead] 9 promot+ vacc9ations ar\nd ! _w ?r\gh-- 7#a7 ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t2 7#b7 ! ,,cdc2 7#c7 ,gavi1 ! ,vacc9e ,alliance2 7#d7 ! ,global ,polio ,eradication ,initiative2 7#e7 ! ,unit$ ,nations ,int]national ,*ildr5's ,em]g5cy ,fund 7commonly kn[n z ,,unicef72 7#f7 ! ,,:o2 & 7#g7 _m o!r multilat]al & nongov]nm5tal organizations3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 comm5ds ! int]national community1 global & dome/ic heal? organizations1 ! private sector1 s*ool & community lead]s1 & fai?-bas$ organizations = _! tireless "w & imm5se contributions to bol/]+ global & dome/ic heal? ?r\gh vacc9ation2 7#b7 affirms t vacc9es & immunizations save lives & are ess5tial to ma9ta9-- 7,a7 ! public heal?2 & 7,b7 ! economic & national security ( ! ,unit$ ,/ates2 7#c7 recognizes t-- 7,a7 l[ vacc9ation rates or ! lack ( vacc9ation c create an environm5t 9 :i* a public heal? crisis c\ld em]ge2 7,b7 vacc9es-- 7i7 are approv$ by ! ,food & ,drug ,adm9i/ration 7ref]r$ to 9 ?is resolv+ clause z ! ,,fda7 z safe & effective2 & 7ii7 meet ! gold /&>d ( safety e/abli%$ by ! ,,fda2 & 7,c7 ! ,c5t]s = ,disease ,control & ,prev5tion advises m$ical provid]s & p>5ts 9 ! ,unit$ ,/ates t ! b5efits ( curr5tly recomm5d$ vacc9es greatly outweigh ! risks ( ^? vacc9es2 7#d7 enc\rages a cont9u$ commitm5t to biom$ical rese>*-- 7,a7 to improve vacc9es2 & 7,b7 to develop new vacc9es aga9/ o!r infecti\s & fatal diseases2 & 7#e7 urges all p1 9 consultation ) _! heal? c>e provid]s1 to foll[ ! sci5tific evid5ce & cons5sus ( m$ical exp]ts 9 favor ( timely vacc9ations to protect-- 7,a7 ! individual vacc9at$2 & 7,b7 ! *ildr51 family1 & community ( ! individual vacc9at$4